وصف
|
Name |
Cat# |
Size |
|
Recombinant Human CLDN18.2 Protein-VLP |
95016ES60 |
100 μg |
|
95016ES80 |
1 mg |
Product Properties
|
Synonyms |
CLDN18.2 / CLD18 / CLDN18 |
|
Source |
HEK293 Cells |
|
AA sequence |
Accession # P56856-1: Met 1 - Val 261 |
|
Endotoxin |
< 1EU per μg by the LAL method. |
|
Purity |
> 85% as determined by DLS. |
|
Formulation |
115mM Gly 4% trehalose |
|
Applications |
ELISA, Kinetics (BLI), Kinetics (SPR), Immunization |
|
dilution |
Dilute with PBS. |
Figure
Figure 1. Immobilized Human CLDN18.2 VLP at 5 ug/mL (30 uL/well) can bind IMAB362 (P04626), The EC50 was approximately 0.008401 ug/ml.
Storage
The product should be stored at -85~-65℃ for 1 year from date of receipt.
Recommend to aliquot the protein into smaller quantities when first used and avoid repeated freeze-thaw cycles.
Cautions
1. Please operate with lab coats and disposable gloves,for your safety.
2. This product is for research use only.
Payment & Security
تتم معالجة معلومات الدفع الخاصة بك بشكل آمن. لا نقوم بتخزين تفاصيل بطاقة الائتمان ولا يمكننا الوصول إلى معلومات بطاقة الائتمان الخاصة بك.
You may also like
Inquiry
FAQ
The product is for research purposes only and is not intended for therapeutic or diagnostic use in humans or animals. Products and content are protected by patents, trademarks, and copyrights owned by Yeasen Biotechnology. Trademark symbols indicate the country of origin, not necessarily registration in all regions.
Certain applications may require additional third-party intellectual property rights.
Yeasen is dedicated to ethical science, believing our research should address critical questions while ensuring safety and ethical standards.